Replies to post #224566 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Let's see: She's a fund manager for Toucan that has at least two funds (as of year end) with a number of portfolio companies, including Cognate prior to its sale, and is a large investor in INMB - she was a director for Cognate and is likely a director for other portfolio companies. NWBO has a grand total of 11 employees in addition to LP, most of whom don't need much daily management, e.g., LG, Boynton and Bosch.

Let me also add, NWBO was cited by their own auditors in the last 10-K for lack of internal controls. Which itself begs questions about appropriate management and oversight.

I have said this before: NWBO is really just a vehicle for holding the patents and raising capital. The trials and much of the legal work are outsourced. The company stays afloat because it raised significant capital from other investors - very simple.

As I've also said before, there is at least one BP that has created problems for this company, but most of the problems are self inflicted.

Fingers crossed, TLD is positive and the company is sold between $2 and $3 a share. That's my expectation.

Please, this is totally inaccurate. Do you have any clue what she does? Part time job?? This is about as insulting a thing anyone could say, let alone ignorant. The amount of mental stress alone would be worth what she gets paid. How on earth do you think a tiny company with so much going on could stay afloat under the enormous pressures it's faced? That is so ridiculous I can't even believe you said it. There are constant licensing issues, clinical trial issues, upcoming trial issues, approval issues, business practice issues, negotiations, etc., etc., etc., infinite and daily fires to put out while trying to stay ahead of other possible and probable developments, all the while working on the strategy and it's implementation for success.

[miltong]

iwasadiver, I agree 100%. Well said.